retatrutide triple hormone receptor agonist obesity investigational drug First Retatrutide phase 3 data, a Triumph of Science! From to Metabolic Health: – Incretin triple agonist retatrutide (LY3437943)
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14




























